Pharmalytics – Q2, 2026 Exclusive Report

• Editorial Column | Six Years In, Still Riding Out the Storm, by Roel Gevaers, Antwerp Management School – UAntwerpen
• From trade flows to exposure maps | How U.S. pharmaceutical and API imports reveal the next phase of logistics resilience
• Pharma market developments | The Next Decade of the Active Pharmaceutical Ingredient Market – Strategic Shifts in Manufacturing, Supply Chains and Global Healthcare (2026–2035)
• Pharma & Life Sciences Logistics Markets Q2 2026 | Local Mergers, Global Investments and Geopolitical Shifts – The most strategically significant developments of the quarter

Pharmalytics – Q1, 2026 Exclusive Report

• Editorial Column by Frank Van Gelder: Resilience must not become the next buzzword
• Pharma Logistics Data: Rewiring global pharmaceutical trade – How geopolitics, supply chain resilience, and strategic control are reshaping a $900 billion global market in 2025-2026.
• Pharma & Life Sciences Logistics Trends: Focus on the global generic medicines sector: from globalisation
  to market dependency, what are the future trajectories?
• Pharma & Life Sciences Logistics Markets: The most strategically significant developments of Q1 2026

Pharmalytics – Q4, 2025 Exclusive Report

• Editorial Column by Prof. Dr. Wouter Dewulf: From “Move Boxes” to “Move Outcomes” Why Pharma Logistics must grow up, fast!
• Pharma Logistics Data: Impact of the current U.S. – China Trade War on the U.S. Imports of Pharmaceuticals and APIs
• Pharma & Life Sciences Logistics Trends: The Supersonic Speed of Medical Innovations – The Transformative Impact on Pharmaceutical Logistics
• Pharma & Life Sciences Logistics Markets: The most strategically significant developments of Q4 2025

Pharmalytics – Q3, 2025 Exclusive Report

• Editorial Column: From Grand Cru to Prosecco, the Next Chapter for Pharma Logistics
  
• Data & Market Insights: Japan’s Healthcare Market
• Industry News: Pharma & Life Sciences Logistics Markets – Q3 2025
• Logistics Trends: The Evolution of AI Integration in Pharmaceutical R&D and the Changing Clinical Trial Landscape from Hospital to At-Home

Pharmalytics – Q2, 2025 Exclusive Report

• Editorial Column:  Training Needs in Pharma Logistics
• Data & Market Insights: The Pharma E-commerce Market – Covers digital disruption in pharmaceutical sales and delivery, key players (Amazon, JD.com), growth projections, and regulatory challenges.
• Industry News: Pharma & Life Sciences Logistics Markets – Q2 2025
• Logistics Trends: Radiopharmaceuticals & Precision Logistics

Pharmalytics – Q1, 2025 Exclusive Report

• Global trade and erosion of predictability: A pharmaceutical perspectiv
• From antibiotics to hormones: A deep dive into the EU’s pharmaceutical ingredient imports
• Mapping global veterinary vaccine trade: Major exporters, importers, and future trends
• Breaking the cold chain: How thermostable technologies are transforming vaccine stability and global logistics
• Pharma & Life Sciences Logistics Markets Q1 2025: Regional mergers, bold integrator moves, and a strategic redirection of supply chains away from geopolitical risk zones

Pharmalytics – Q4, 2024 Exclusive Report

• In-Depth Analysis of Europe’s Pharmaceutical Export Growth, Trade Flows, and Key Market Subcategories
• Key Developments in Pharma Logistics for 2024: Mergers, Technological Advancements, and Geopolitical Impact
• Disrupting Healthcare: The Digital-to-Consumer Shift and the Role of Smart Hospitals in Advancing Medtech and Pharma Innovation

Pharmalytics – Q3, 2024 Exclusive Report

• Data & analytics on global product flows through major airports and maritime ports
• Key insights on supply chain trends, including sustainability, innovation, and regulatory shifts
• Updates on new product designs and their impact on logistics
• A detailed overview of ecosystem developments, including partnerships, digital transformation, and CSR